Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer

NCT00470067 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Due to low accrual

Conditions

Endometrial Cancer

Interventions

DRUG: carboplatin
DRUG: pegylated liposomal doxorubicin hydrochloride

Sponsor

Roswell Park Cancer Institute